On the initiative of FMC BioPolymer AS, AlgiPharma was established, financed and began operating as an independent company. AlgiPharma is a biopharmaceutical company that aims to develop medicinal products within the areas of respiratory diseases, wound healing and other infectious diseases.
For further information, please contact:
Arne Dessen, Chairman of Board, +47 95170278; email@example.com
Yngvar P. Berg, CEO, +47 90044903; firstname.lastname@example.org